Sage Journals: Discover world-class research

Abstract

Objective:

The aim of this research was to determine correlates of prevalent cervicovaginal human papillomavirus (HPV) infection in perimenopausal women.

Methods:

A total of 178 women, ages 40–60, were recruited from four clinics in the metropolitan area of Baltimore, Maryland. A self-collected cervicovaginal specimen and questionnaire were completed following enrollment and consent. HPV was detected by L1 consensus polymerase chain reaction (PCR) and genotyped using a prototype line blot assay. Adjusted prevalence ratios (aPR) and 95% confidence intervals (CIs) from Poisson regression models with robust variance identified correlates of prevalent HPV infection.

Results:

Prevalence of any HPV genotype at baseline among 172 women with complete data was 20% (6% for high-risk HPV). HPV prevalence was higher among single compared to married women (aPR = 4.3 [95% CI: 2.0, 9.5]), and among women with ≥2 sex partners in the last six months compared to women who reported none (aPR = 4.9 [1.7, 13.9]) after adjustment for confounders. Menopausal stage was also associated with HPV detection, with increased prevalence among perimenopausal compared to premenopausal women (aPR 2.3 [1.1, 5.1]), after adjustment for confounders. Age was moderately correlated with menopausal staging (r = 0.57).

Conclusions:

Our observations suggest the independent associations of sexual behavior and hormones on prevalent HPV in perimenopausal women. Age was not a good surrogate for menopausal stage, as it was only moderately correlated with menopausal stage.

Get full access to this article

View all access options for this article.

References

Clifford

, Gallus

, Herrero

et al. Worldwide distribution of human papillomavirus types in cytologically normal women in the International Agency for Research on Cancer HPV prevalence surveys: a pooled analysis. Lancet, 2005; 366:991–998.

de Sanjose

, Diaz

, Castellsague

et al. Worldwide prevalence and genotype distribution of cervical human papillomavirus DNA in women with normal cytology: a meta-analysis. Lancet Infect Dis, 2007; 7:453–459.

Bosch

, Lorincz

, Munoz

et al. The causal relation between human papillomavirus and cervical cancer. J Clin Pathol, 2002; 55:244–265.

Walboomers

, Jacobs

, Manos

et al. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol, 1999; 189:12–19.

zur Hausen

. Papillomaviruses and cancer: from basic studies to clinical application. Nat Rev Cancer, 2002; 2:342–350.

Schiffman

, Kjaer

. Chapter 2: Natural history of anogenital human papillomavirus infection and neoplasia. J Natl Cancer Inst Monogr, 2003; 31:14–19.

Hale

, Burger

. Hormonal changes and biomarkers in late reproductive age, menopausal transition and menopause. Best Pract Res Clin Obstet Gynaecol, 2009; 23:7–23.

Straub

. The complex role of estrogens in inflammation. Endocrinol Rev, 2007; 28:521–574.

Soules

, Sherman

, Parrott

et al.

Stages of Reproductive Aging Workshop (STRAW)

J Womens Health Gend Based Med, 2001; 10:843–848.

10.

Gravitt

, Peyton

, Alessi

et al. Improved amplification of genital human papillomaviruses. J Clin Microbiol, 2000; 38:357–361.

11.

Gravitt

, Peyton

, Apple

et al. Genotyping of 27 human papillomavirus types by using L1 consensus PCR products by a single-hybridization, reverse line blot detection method. J Clin Microbiol, 1998; 36:3020–3027.

12.

Behrens

, Taeger

, Wellmann

et al. Different methods to calculate effect estimates in cross-sectional studies. A comparison between prevalence odds ratio and prevalence ratio. Methods Inf Med, 2004; 43:505–509.

13.

Ferenczy

, Gelfand

, Franco

et al. Human papillomavirus infection in postmenopausal women with and without hormone therapy. Obstet Gynecol, 1997; 90:7–11.

14.

Smith

, Ritchie

, Levy

et al. Prevalence and persistence of human papillomavirus in postmenopausal age women. Cancer Detect Prev, 2003; 27:472–480.

15.

Smith

, Johnson

, Figuerres

et al. The frequency of human papillomavirus detection in postmenopausal women on hormone replacement therapy. Gynecol Oncol, 1997; 65:441–446.

16.

Smith

, Levy

, Ritchie

et al.

Is use of hormone replacement therapy associated with increased detection of human papillomavirus and potential risk of HPV-related genital cancers?

Eur J Cancer Prev, 2002; 11:295–305.

17.

Sowers

, Crawford

, Sternfeld

et al. Lobo

, Kelsey

, Marcus

. SWAN: A multicenter, multiethnic, community-based cohort study of women and the menopausal transition. Menopause: biology and pathobiology. San Diego: Academic Press, 2000; 175–188.

18.

Santoro

, Lasley

, McConnell

et al. Body size and ethnicity are associated with menstrual cycle alterations in women in the early menopausal transition: The Study of Women's Health across the Nation (SWAN) Daily Hormone Study. J Clin Endocrinol Metab, 2004; 89:2622–2631.

19.

Gravitt

, Lacey

Jr. , Brinton

et al. Evaluation of self-collected cervicovaginal cell samples for human papillomavirus testing by polymerase chain reaction. Cancer Epidemiol Biomarkers Prev, 2001; 10:95–100.

20.

Herrero

, Hildesheim

, Rodriguez

et al. Rationale and design of a community-based double–blind randomized clinical trial of an HPV 16 and 18 vaccine in Guanacaste, Costa Rica. Vaccine, 2008; 26:4795–4808.

21.

Karwalajtys

, Howard

, Sellors

et al. Vaginal self sampling versus physician cervical sampling for HPV among younger and older women. Sex Transm Infect, 2006; 82:337–339.

22.

Safaeian

, Kiddugavu

, Gravitt

et al. Comparability of self-collected vaginal swabs and physician-collected cervical swabs for detection of human papillomavirus infections in Rakai, Uganda. Sex Transm Dis, 2007; 34:429–436.

23.

Petignat

, Faltin

, Bruchim

et al. Are self-collected samples comparable to physician-collected cervical specimens for human papillomavirus DNA testing? A systematic review and meta-analysis. Gynecol Oncol, 2007; 105:530–535.

24.

Castle

, Rodriguez

, Porras

et al. A comparison of cervical and vaginal human papillomavirus. Sex Transm Dis, 2007; 34:849–855.

Correlates of Cervicovaginal Human Papillomavirus Detection in Perimenopausal Women

Abstract

Objective:

Methods:

Results:

Conclusions:

Get full access to this article

References